UGCG and neoplasm: Preclinical studies consistently demonstrate that inhibition of UGCG attenuates key malignant phenotypes, including suppression of tumor cell proliferation, inhibition of metastatic spread, reduction in immune cell infiltration, and impairment of tumor-associated angiogenesis (Table 4).